Literature DB >> 33599404

Diagnosis of type 1 diabetes during the SARS-CoV-2 pandemic: Does lockdown affect the incidence and clinical status of patients?

Agnieszka Zubkiewicz-Kucharska1, Monika Seifert1, Michał Stępkowski1, Anna Noczyńska1.   

Abstract

BACKGROUND: Currently, the only effective method to control the spread of the COVID-19 pandemic is social distancing. The lockdown measures during the epidemic may have an impact on the presentation of diabetes and may disturb metabolic control.
OBJECTIVES: In order to address the hypothesis that the COVID-19 lockdown affected the incidence rate (IR) of type 1 diabetes (T1D) in the pediatric population of Lower Silesia and the patients' clinical status, the incidence of T1D during the COVID-19 pandemic was analyzed.
MATERIAL AND METHODS: Incidence estimates were obtained from the T1D pediatric registry for Lower Silesia which has been maintained since January 1, 2000. The observation was completed on April 30, 2020.
RESULTS: A total of 1961 cases were diagnosed (1054 boys, 53.72%). An increase in the T1D IR was observed, from 10.43/100,000/year in 2000 to 22.06/100,000/year in 2019. The seasonality of T1D incidence was also observed, with the highest IR appearing in January and February. There were half as many cases of T1D in March and April 2020 as in the same months in 2019 (p > 0.05). Diabetic ketoacidosis (DKA) occurred in 31.75% of patients in years 2000-2019, comparably (p > 0.05) to 2020 (36.67% patients), including March and April (50% of patients). The duration of hyperglycemia symptoms was 20.2 ±25.4 days, which was comparable to 2020 (13.1 ±10.96 days; p = 0.1675) and March and April of 2020 (9.67 ±5.63 days; p = 0.0831). Glycated hemoglobin (HbA1c) level was 11.79 ±2.63%, which was comparable to March and April of 2020 (13.06 ±2.35%; p = 0.1171), while in all of 2020 it was 13.41 ±2.50% (p = 0.0003).
CONCLUSIONS: The IR of T1D in Lower Silesian children in the months of the COVID-19 pandemic was comparable to previous years, while their clinical condition at the time of diagnosis was worse than in previous years.

Entities:  

Keywords:  COVID-19 pandemic; incidence rate; type 1 diabetes

Year:  2021        PMID: 33599404     DOI: 10.17219/acem/130359

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  9 in total

1.  NUTRITIONAL HABITS, COMPLIANCE WITH HEALTHY DIET AND INSULIN THERAPY, DEPRESSION AND FAMILY FUNCTIONALITY IN CHILDREN WITH TYPE 1 DIABETES MELLITUS DURING THE COVID-19 PANDEMIC PERIOD.

Authors:  S B Koca; A Bükülmez; A T Oflu; E G Tahta; H Demirbilek
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

Review 2.  Environmental Factors and the Risk of Developing Type 1 Diabetes-Old Disease and New Data.

Authors:  Katarzyna Zorena; Małgorzata Michalska; Monika Kurpas; Marta Jaskulak; Anna Murawska; Saeid Rostami
Journal:  Biology (Basel)       Date:  2022-04-16

Review 3.  COVID-19-Induced New-Onset Diabetes: Trends and Technologies.

Authors:  Ahmed A Metwally; Pranav Mehta; Brian S Johnson; Anvith Nagarjuna; Michael P Snyder
Journal:  Diabetes       Date:  2021-10-22       Impact factor: 9.461

4.  Has the COVID-19 Pandemic Affected the Prevalence of Diabetic Ketoacidosis in Polish Children with Newly Diagnosed Type 1 Diabetes? An Example of the Largest Polish Pediatric Diabetes Center (Upper Silesia-Katowice, Poland).

Authors:  Ewa Rusak; Sebastian Seget; Maksymilian Macherski; Natalia Furgał; Przemysław Dyś; Przemysława Jarosz-Chobot
Journal:  Healthcare (Basel)       Date:  2022-02-11

5.  Impact of the COVID-19 Pandemic on the Severity of Diabetic Ketoacidosis Presentations in a Tertiary Pediatric Emergency Department.

Authors:  Kaileen Jafari; Ildiko Koves; Lori Rutman; Julie C Brown
Journal:  Pediatr Qual Saf       Date:  2022-03-30

6.  Incidence of Diabetic Ketoacidosis Among Pediatrics With Type 1 Diabetes Prior to and During COVID-19 Pandemic: A Meta-Analysis of Observational Studies.

Authors:  Osamah M Alfayez; Kholood S Aldmasi; Nada H Alruwais; Nouf M Bin Awad; Majed S Al Yami; Omar A Almohammed; Abdulaali R Almutairi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-09       Impact factor: 5.555

7.  Incidence of diabetic ketoacidosis during COVID-19 pandemic: a meta-analysis of 124,597 children with diabetes.

Authors:  Anas Elgenidy; Ahmed K Awad; Khaled Saad; Mostafa Atef; Hatem Helmy El-Leithy; Ahmed A Obiedallah; Emad M Hammad; Faisal-Alkhateeb Ahmad; Ahmad M Ali; Hamad Ghaleb Dailah; Amira Elhoufey; Samaher Fathy Taha
Journal:  Pediatr Res       Date:  2022-08-11       Impact factor: 3.953

8.  Missing Diagnoses during the COVID-19 Pandemic: A Year in Review.

Authors:  Héctor Pifarré I Arolas; Josep Vidal-Alaball; Joan Gil; Francesc López; Catia Nicodemo; Marc Saez
Journal:  Int J Environ Res Public Health       Date:  2021-05-17       Impact factor: 3.390

Review 9.  Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron (B.1.1.529).

Authors:  Akiko Yonekawa; Nobuyuki Shimono
Journal:  Biology (Basel)       Date:  2022-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.